These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2681741)

  • 1. Response to the antiprogestagen RU 486 (mifepristone) during early pregnancy and the menstrual cycle in women.
    Spitz IM; Shoupe D; Sitruk-Ware R; Mishell DR
    J Reprod Fertil Suppl; 1989; 37():253-60. PubMed ID: 2681741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined use of prostaglandin and antiprogestin in human fertility control.
    Baulieu EE
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():55-62. PubMed ID: 7732905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of action of RU 486.
    Bygdeman M; Swahn ML; Gemzell-Danielsson K; Svalander P
    Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteal phase contraception with mifepristone (RU 486) in the rhesus monkey.
    Ghosh D; De P; Sengupta J
    Indian J Physiol Pharmacol; 1994 Jan; 38(1):17-22. PubMed ID: 8132238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiprogesterones.
    Norman J
    Br J Hosp Med; 1991 Jun; 45(6):372-5. PubMed ID: 2070168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mifepristone on inhibition of ovulation and induction of luteolysis.
    Spitz IM; Croxatto HB; Lähteenmäki P; Heikinheimo O; Bardin CW
    Hum Reprod; 1994 Jun; 9 Suppl 1():69-76. PubMed ID: 7962472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RU 486: an overview of mifepristone and its potential applications.
    Contracept Rep; 1993 May; 4(2):7-9. PubMed ID: 12286473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical use of RU 486 (Mefipristone).
    Herrmann W
    Res Reprod; 1989 Oct; 21(4):3. PubMed ID: 12282921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RU 486 (mifepristone): from clinical trials to the perspectives for clinical use.
    Elia D; Ulmann A
    Contracept Fertil Sex (Paris); 1986 Dec; 14(12):1099-103. PubMed ID: 12314688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward developing a once-a-month pill: a double-blind, randomized, controlled trial of the effect of three single doses of mifepristone given at midcycle on the pattern of menstrual bleeding.
    Narvekar N; Glasier A; Dada K; Van der Spuy Z; Ho PC; Cheng L; Baird DT
    Fertil Steril; 2006 Oct; 86(4):819-24. PubMed ID: 17027354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.
    Papp C; Schatz F; Krikun G; Hausknecht V; Lockwood CJ
    Early Pregnancy (Cherry Hill); 2000 Oct; 4(4):230-9. PubMed ID: 11742418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contranidatory activity of early luteal phase administration of mifepristone in the rhesus monkey.
    Ghosh D; De P; Sengupta J
    Indian J Physiol Pharmacol; 1993 Jan; 37(1):13-8. PubMed ID: 8449539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteolysis in humans and subhuman primates.
    Henzl MR
    Res Prostaglandins; 1972 May; 1(5):1-3. PubMed ID: 12337004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of anti-progesterones as a medical IUD.
    Nieman LK; Loriaux DL
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):609-16. PubMed ID: 3233821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraceptive potential of RU 486 by ovulation inhibition: III. Preliminary observations on once weekly oral administration.
    Danforth DR; Dubois C; Ulmann A; Baulieu EE; Hodgen GD
    Contraception; 1989 Aug; 40(2):195-200. PubMed ID: 2503298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One day estrous cycle shortening induced by antiprogestagen RU486 administration in proestrus to 4-day cyclic rats.
    Tébar M; Ruiz A; Sánchez-Criado JE
    Rev Esp Fisiol; 1995 Jun; 51(2):85-91. PubMed ID: 8532955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new antiprogestational compound, mifepristone (RU-486)].
    Parisi C; Steffe M
    Patol Clin Ostet Ginecol; 1988; 16(4):291-4. PubMed ID: 12345008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menstrual regulation by mifepristone plus prostaglandin: results from a multicentre trial. World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation.
    Hum Reprod; 1995 Feb; 10(2):308-14. PubMed ID: 7769054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contragestion with late luteal administration of RU 486 (Mifepristone).
    Dubois C; Ulmann A; Baulieu EE
    Fertil Steril; 1988 Oct; 50(4):593-6. PubMed ID: 3049166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.